Nektar Therapeutics
NKTR
NKTR
145 hedge funds and large institutions have $1.43B invested in Nektar Therapeutics in 2014 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 59 increasing their positions, 45 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
145
Holders Change
+1
Holders Change %
+0.69%
% of All Funds
4.21%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
18
Increased
59
Reduced
45
Closed
16
Calls
$10.7M
Puts
$2.61M
Net Calls
+$8.11M
Net Calls Change
-$4.68M
Top Buyers
| 1 |
Primecap Management
Pasadena,
California
|
+$28.2M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$12.7M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
+$10.6M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.28M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$5.43M |
Top Sellers
| 1 |
Franklin Resources
San Mateo,
California
|
-$20.9M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$8.35M |
| 3 |
State Street
Boston,
Massachusetts
|
-$6.25M |
| 4 |
Barclays
London,
United Kingdom
|
-$4.95M |
| 5 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$3.04M |
